Precision Medicine Online provides the latest news for healthcare leaders and scientists interested in precision medicine and individualized approaches to treatment and prevention.

2025年2月10日 · The firm will offer up to 12,030,218 common shares for Keystone Capital Partners to sell and is expecting to net around $2.1 million in gross proceeds.

2 天之前 · NEW YORK – Boehringer Ingelheim on Wednesday said the US Food and Drug Administration accepted its new drug application for the irreversible tyrosine kinase inhibitor zongertinib as a treatment for patients with unresectable or metastatic non-small cell lung cancer with HER2 mutations who have received previous systemic therapy.

2025年2月14日 · The European Commission granted approval for von Hippel-Lindau-associated renal cell carcinoma, CNS hemangioblastomas, or pancreatic neuroendocrine tumors.

2 天之前 · NEW YORK – A new artificial intelligence-driven clinical decision support tool aims to guide the choice of frontline therapy for pancreatic cancer patients and, its developers say, underscores the importance of next-generation sequencing for newly diagnosed patients. Using its AI-driven precision ...

1 天前 · NEW YORK – Real-world data have illuminated emerging treatment patterns for Novartis' radiopharmaceutical Pluvicto (lutetium Lu 177 vipivotide tetraxetan) in both academic and community oncology settings. The new research, presented at the 2025 American Society of Clinical Oncology Genitourinary ...

News and analysis on disease research and diagnostics from Precision Medicine Online.

2025年1月6日 · NEW YORK – The US Food and Drug Administration in 2024 approved dozens of new and expanded precision medicine indications. Although most of these approvals were still in cancer and rare conditions, the field of precision medicine is poised to enter bigger markets for Alzheimer's, heart, and autoimmune diseases that could better patients' lives — if they can afford and access them.

2024年12月19日 · NEW YORK – The use of artificial intelligence in precision medicine research and development surged in 2024 as researchers in industry and academia explored ways to leverage the technology to improve cancer diagnoses, predict …

2024年12月30日 · NEW YORK – In 2024, Precision Medicine Online readers were most interested in stories tracking the implementation of personalized treatments and tests for cancer, cardiovascular disease, and rare conditions. An annual survey tracking the investments US cancer centers and hospitals are making in precision …